Literature DB >> 15551330

hOGG1 Ser326Cys polymorphism and G:C-to-T:A mutations: no evidence for a role in tobacco-related non small cell lung cancer.

Ying Chuan Hu1, Steven A Ahrendt.   

Abstract

Human 8-oxoguanine DNA glycosylase 1 (hOGG1) plays a major role in the repair of 8-hydroxyguanine, one of the major forms of DNA damage generated by reactive oxygen species in tobacco smoke. If left unrepaired by hOGG1, 8-hydroxyguanine can produce G:C-to-T:A transversions. Recent studies have suggested that the hOGG1 Ser326Cys polymorphism is associated with both a decrease in enzyme activity and an increased risk of lung cancer. To define the interaction between tobacco carcinogens, hOGG1-mediated DNA repair and DNA damage, we examined the role of the hOGG1 Ser326Cys polymorphism in mutation of the p53 gene in non small cell lung cancer (NSCLC). Tumor and nonneoplastic DNA were collected from 141 cigarette smokers with NSCLC. p53 mutations were detected by direct dideoxy sequencing and/or the GeneChip p53 assay in 74 of the 141 (52%) tumors. hOGG1 codon 326 polymorphisms were identified by polymerase chain reaction-restriction fragment length polymorphism analysis. The distribution of hOGG1 codon 326 genotypes was Ser/Ser, 90 of 141 (64%); Ser/Cys, 45 of 141 (32%); and Cys/Cys, 6 of 141 (4%). p53 mutations were significantly (p = 0.04) less common in NSCLC from patients with codon 326 Ser/Cys or Cys/Cys genotypes (21 of 51; 41%) than in NSCLC from Ser/Ser homozygotes (53 of 90; 59%). The decrease in p53 mutation frequency among carriers of the Cys allele was more evident in lung squamous cell cancer [7 of 17 (41%) for Cys/Cys and Ser/Cys vs. 27 of 38 (71%) for Ser/Ser; p = 0.04] than in nonbronchoalveolar adenocarcinoma [11 of 26 (42%) for Cys/Cys and Ser/Cys vs. 20 of 35 (57%) for Ser/Ser; p = 0.25]. The prevalence of G:C-to-T:A transversions was similar among hOGG1 codon 326 genotypes. In summary, the hOGG1 codon 326 Cys allele was associated with a decrease in p53 mutations and no effect on G:C-to-T:A transversions in NSCLC. This decrease in p53 mutations in vivo is not consistent with a decrease in the repair of 8-hydroxyguanine among carriers of the hOGG1 codon 326 Cys allele in vitro. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15551330     DOI: 10.1002/ijc.20730

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

Review 1.  Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk.

Authors:  Jong Y Park; Yifan Huang; Thomas A Sellers
Journal:  Methods Mol Biol       Date:  2009

2.  Identifying a novel role for X-prolyl aminopeptidase (Xpnpep) 2 in CrVI-induced adverse effects on germ cell nest breakdown and follicle development in rats.

Authors:  Sakhila K Banu; Jone A Stanley; Kirthiram K Sivakumar; Joe A Arosh; Rola Barhoumi; Robert C Burghardt
Journal:  Biol Reprod       Date:  2015-01-07       Impact factor: 4.285

3.  DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.

Authors:  L Letkova; T Matakova; L Musak; M Sarlinova; M Krutakova; P Slovakova; E Kavcova; V Jakusova; M Janickova; A Drgova; P Berzinec; E Halasova
Journal:  Mol Biol Rep       Date:  2013-05-15       Impact factor: 2.316

4.  Evaluating chromosomal damage in workers exposed to hexavalent chromium and the modulating role of polymorphisms of DNA repair genes.

Authors:  Erika Halasova; Tatiana Matakova; Ludovit Musak; Veronika Polakova; Lucia Letkova; Dusan Dobrota; Pavel Vodicka
Journal:  Int Arch Occup Environ Health       Date:  2011-08-20       Impact factor: 3.015

5.  Association of hOGG1-Cys variants with occurrence of p53 and EGFR deletion mutations in non-small cell lung cancer.

Authors:  Ming-Jenn Chen; Ching-Ju Shen; Lee Wang; Po-Ming Chen; Chih-Yi Chen; Huei Lee
Journal:  Thorac Cancer       Date:  2020-12-28       Impact factor: 3.500

6.  The APE1 Asp/Asp genotype and the combination of APE1 Asp/Asp and hOGG1-Cys variants are associated with increased p53 mutation in non-small cell lung cancer.

Authors:  Chun-Hsuan Lin; Po-Ming Chen; Ya-Wen Cheng; Chih-Yi Chen; Chiun-Jye Yuan; Huei Lee
Journal:  J Epidemiol       Date:  2012-09-29       Impact factor: 3.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.